CIK 0001237831 · Large accelerated filer
GLOBUS MEDICAL INC
Sign in to watch- Ticker
- GMED
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043744954
- Phone
- 610-930-1800
- Business address
- 2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,970,014
- in 4 filings, $425K under 10b5-1 plans
Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-06 | Scavilla Daniel T President, CEO | Sale 10b5-1 | −60,000 | $80.02 | $4.8M | 0 |
| 2024-11-06 | Scavilla Daniel T President, CEO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | +30,000 | 0 | ||
| 2024-11-06 | Scavilla Daniel T President, CEO | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | +30,000 | 50,000 | ||
| 2024-10-16 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise 10b5-1 | +7,500 | $25.80 | $194K | 7,500 |
| 2024-10-16 | Huller Kelly SVP, GC, Corporate Secretary | Sale 10b5-1 | −7,500 | $75.02 | $563K | |
| 2024-10-16 | Huller Kelly SVP, GC, Corporate Secretary | Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 | −7,500 | 0 | ||
| 2024-10-16 | Davidar David D Director | Sale 10b5-1 | −30,000 | $75.04 | $2.3M | 536,275 |
| 2024-10-16 | Davidar David D Director | Sale 10b5-1 | −20,000 | $75.03 | $1.5M | 185,967 |
| 2024-09-13 | RHOADS ANN D Director | Option exercise | +15,000 | $24.10 | $362K | 37,884 |
| 2024-09-13 | RHOADS ANN D Director | Option exercise | +20,000 | $25.52 | $510K | 57,884 |
| 2024-09-13 | RHOADS ANN D Director | Sale | −15,000 | $70.36 | $1.1M | 42,884 |
| 2024-09-13 | RHOADS ANN D Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −15,000 | 0 | ||
| 2024-09-13 | RHOADS ANN D Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −20,000 | 0 | ||
| 2024-09-13 | Davidar David D Director | Option exercise | +25,000 | $25.52 | $638K | 591,275 |
| 2024-09-13 | Davidar David D Director | Sale | −25,000 | $70.46 | $1.8M | 566,275 |
| 2024-09-13 | Davidar David D Director | Option exercise · Stock Option (Right to Buy Class A Common Stock) | −25,000 | 25,000 | ||
| 2024-07-11 | Norwalk Leslie V Director | Sale 10b5-1 | −1,000 | $70.00 | $70K | 16,419 |
| 2024-05-10 | Lemaitre Dan Director | Option exercise | +17,500 | $43.77 | $766K | 28,300 |
| 2024-05-10 | Lemaitre Dan Director | Option exercise | +17,500 | $43.58 | $763K | 45,800 |
| 2024-05-10 | Lemaitre Dan Director | Option exercise | +17,500 | $53.27 | $932K | 63,300 |
Page 7 of 10 · 200 trades